Compare ROMA & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ROMA | BME |
|---|---|---|
| Founded | 2018 | N/A |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Trusts Except Educational Religious and Charitable |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 520.6M | 576.8M |
| IPO Year | 2022 | 2005 |
| Metric | ROMA | BME |
|---|---|---|
| Price | $6.60 | $46.90 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 46.4K | 37.4K |
| Earning Date | 07-31-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.16 | $37.51 |
| 52 Week High | $11.77 | $46.75 |
| Indicator | ROMA | BME |
|---|---|---|
| Relative Strength Index (RSI) | 40.11 | 67.98 |
| Support Level | $6.01 | $41.77 |
| Resistance Level | $8.53 | N/A |
| Average True Range (ATR) | 0.80 | 0.70 |
| MACD | -0.14 | 0.26 |
| Stochastic Oscillator | 42.72 | 84.20 |
Roma Green Finance Ltd is a professional specialist in the provision of environmental, social and governance (ESG), sustainability and climate change related advisory services through its operating subsidiaries in Hong Kong and Singapore. Its services include Sustainability Program Development, ESG Reporting, Corporate Governance and Risk Management, Climate Change Strategies and Solutions, Environmental Audit, ESG Rating Support and Shareholder Communication, and Education and Training. It operates in one reporting business segment in Hong Kong and Singapore, of which the majority of revenue is derived from Hong Kong.
Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.